Vascular damage from smoking: Disease mechanisms at the arterial wall

Vascular Medicine

Volumn 3, Issue 1, 1998, Pages 21-28

  Powell, Janet T ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Endothelium; Fibrinogen; Nitric oxide; Smoking

Indexed keywords

ASCORBIC ACID; LOW DENSITY LIPOPROTEIN;

ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; HUMAN; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LIPID OXIDATION; PASSIVE SMOKING; PRIORITY JOURNAL; SMOKING; VASCULAR ENDOTHELIUM;

EID: 0031805174     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358836x9800300105     Document Type: Article

References (84)

1. Phillips DH, Hewer A, Martin CN, Garner RC, King MM. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature 1988; 336: 790-92.
2. 32P-postlabeling assay. J Natl Cancer Inst 1989; 81: 341-47.
3. Kiryluk S, Wald N. Trends in smoking habits in the United Kingdom. In: Wald N, Froggat P eds. Nicotine, smoking and the low tar programme Oxford: Oxford Medical Publications, 1989: 53-69.
4. Negri E, Franzosi MG, La Vecchia C, Santoro L, Nobili A, Tognoni G Tar yields of cigarettes and risk of acute myocardial infarction. Br Med J 1993; 306: 1567-70.
5. Powell JT, Edwards RJ, Worrell PC, Franks PJ, Greeenhalgh RM, Poulter NR. Risk factors associated with the development of peripheral arterial disease in smokers. Atherosclerosis 1997; 129: 41-48.
6. Franks PJ, Edwards RJ, Greenhalgh RM, Powell JT Risk factors for the development of abdominal aortic aneurysm in smokers. Eur J Vasc Surg 1996; 11: 487-92.
7. Nutt DJ. Addiction: brain mechanisms and their treatment implications. Lancet 1996; 347: 31-36.
8. Benwell MEM, Balfour DJK, Birrell CE. Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine. Br J Pharmacol 1995; 114: 454-60.
9. Pontieri FE, Tanda G, Orzi F, di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996; 382: 255-57.
10. 3H]nicotine binding sites in human brain. J Neurochem 1988; 50: 1243-47.
11. Fowler JS, Volkow ND, G-J Wang et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 1996; 379: 733-36.
12. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988; 319: 1318-30.
13. Wald NJ, Boreham J, Bailey A. Relative intakes of tar, nicotine and carbon monoxide from cigarettes of different yield. Thorax 1984; 39: 361-64.
14. Worrell PC, Edwards RJ, Powell JT. Smoking markers as a reflection of the smoking habit. J Smoking Relat Dis 1995; 6: 89-98.
15. Ernst E, Matrai A, Schmolzl C, Magyarosy I. Dose-effect relationship between smoking and blood rheology. Br J Haemotol 1987; 65: 485-87.
16. Fischer S, Spiegelhalter B, Preussmann R. Tobacco-specific nitrosamines in commercial cigarettes: possibilities for reducing exposure. IARC Sci Publ 1991; 105: 489-92.
17. Marks DS, Vita JA, Folts JD, Keaney JF, Welch GN, Loscalzo J. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest 1995; 96: 2630-38.
18. Heitzer T, Just H, Münzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996; 94: 6-9.
19. Fuller CJ, Grundy SM, Norkus EP, Jiala I. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers. Atherosclerosis 1996; 119: 139-50.
20. Hammond EC, Garfinkel L. Coronary heart disease, stroke and abdominal aortic aneurysm. Factors in etiology Arch Environ Health 1967; 19: 167-82.
21. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 1976; ii: 1525-36.
22. Abbott RD, Yin Y, Reed DM, Yano K. Risk of stroke in male cigarette smokers. N Engl J Med 1986; 315: 717-20.
23. Adamson J, Humphries SE, Voldby B, Ostergaard J, Richards P, Powell JT. Are cerebral aneurysms atherosclerotic? Stroke 1994; 25: 963-66.
24. Kannel WB, Shurtleff D. The Framingham Study: cigarettes and the development of intermittent claudication. Geriatrics 1973; 28: 61-68.
25. Fowkes FGR Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg 1988; 2: 283-91.
26. Fowkes FGR, Housley E, Riemersma RA et al. Smoking, lipids, glucose intolerance and blood pressure as risk factors for peripheral atherosclerosis in the Edinburgh Artery Study. Am J Epidemiol 1992; 135: 331-40.
27. Pocock SJ, Cook DG, Shaper AG, Kussick SJ. Giving up smoking and the risk of heart attacks: A report from the British Regional Heart Study Lancet 1986; ii; 1376-79.
28. Smith I, Franks PJ, Greenhalgh RM, Poulter NR, Powell JT. The influence of smoking cessation and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia. Eur J Vasc Surg 1996; 11: 487-92.
29. MacSweeney STR, Ellis M, Worrell PC, Greenhalgh RM, Powell JT. Smoking and growth rate of small abdominal aortic aneurysms. Lancet 1994; 344: 651-52.
30. Wiseman S, Kenchington G, Dain R, McCollum C, Greenhalgh RM, Powell JT. Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. Br Med J 1989; 299: 643-46.
31. Bornmyr S, Soensson H. Thermomography and laser-Doppler flowmetry for monitoring changes in finger skin blood flow upon cigarette smoking. Clin Physiol 1991; 11: 135-41.
32. Levine LA, Gerber GS. Acute vasospasm of penile arteries in response to cigarette smoking. Urology 1990; 36: 99-100.
33. Asmussen I, Kjeldsen K. Intimal ultrastructure of human umbilical arteries. Observations on arteries from newborn children of smoking and non-smoking mothers. Circulation Res 1975; 36: 579-89.
34. Brooke OG, Anderson HR, Bland JM, Peacock JL, Stewart CM. Effects on birth weight of smoking, alcohol, caffeine, socioeconomic factors and psychosocial stress. Br Med J 1989; 298: 795-801.
35. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence Br Med J 1997; 315: 973-80.
36. Celermajer DS, Adams MR, Clarkson P et al. Passive smoking and impaired endothelium-dependent arterial dilation in healthy young adults. N Engl J Med 1996; 334: 150-54.
37. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986; 314: 488-500.
38. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 1993; 362: 801-809.
39. Strong JP, Richards ML. Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis 1976; 23: 451-76.
40. Davies M, Bland J, Haugartner J, Angelini A, Thomas A. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. Eur Heart J 1989; 10: 203-208.
41. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-15.
42. Heitzer T, Ylä-Herttuala S, Luoma J et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996; 93: 1346-53.
43. Higman DJ, Strachan AMJ, Buttery L et al. Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein. Arterioscler Thromb Vasc Biol 1996; 16: 546-52.
44. Ichiki K, Ikeda H, Haramaki N, Ueno T, Imaizumi T. Long-term smoking impairs platelet-derived nitric oxide release. Circulation 1996; 94: 3109-14.
45. Cosentino F, Katušić. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries Circulation 1995; 91: 139-44.
46. Celermajer DS, Sorensen KE, Georgakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149-55.
47. Higman DJ, Strachan AMJ, Powell JT. Reversibility of smoking-induced endothelial dysfunction. Br J Surg 1994; 81: 977-78.
48. Lassila R, Seyberth HW, Haapanen A et al. Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking. Br Med J 1988; 297: 955-57.
49. Davies MJ, Woolf N. Atherosclerosis: what is it and why does it occur? Br Heart J 1993; 69(suppl): S3-S11.
50. Springer TA. Traffic signals for lymphocyte recirculation and leucocyte emigration: the multistep paradigm. Cell 1994; 76: 301-14.
51. Tsao PS, Lewis NP, Alpert S, Cooke JP. Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide. Circulation 1995; 92: 3513-19.
52. Shen Y, Rattan V, Sultana L, Kalra VK. Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytes. Am J Physiol 1996; 270: H1624-H33.
53. Weber C, Erl W, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996; 93: 1488-92.
54. Caro CG, Lever MJ, Parker KH, Fish PJ. Effect of cigarette smoking on pattern of arterial blood flow possible insight into mechanism and the underlying development of atherosclerosis. Lancet 1987, ii: 11-13.
55. Resnick N, Gimbrone MA. Haemodynamic forces are complex regulators of endothelial gene expression. FASEB J 1995; 9: 852-60.
56. Sbarbati R, de Boer M, Maizilli M, Scarlattini M, Rossi G, van Mourik JA. Immunologic detection of endothelial cells in human whole blood. Blood 1991; 77: 764-769.
57. Frei B, Forte TM, Ames BN, Cross CE. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Biochem J 1991; 277: 133-38.
58. Fuster V, Chesebro JH, Frye R, Elveback LR Platelet survival and the development of coronary artery disease in young adults. Circulation 1981; 63: 546-51.
59. Nowak J, Murray JJ, Oates JA, FitzGerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 1987; 76: 6-14.
60. Ashby P, Dalby AM, Millar JH. Smoking and platelet stickiness. Lancet 1965; ii: 158-60.
61. Mansouri A, Perry CA. Inhibition of platelet ADP and serotonin release by carbon monoxide in cigarette smokers. Experimentia 1984; 40: 515-17.
62. Meade TW, Mellows S, Brozovic M et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study [see comments]. Lancet 1986; ii: 533-37.
63. Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y, Thomas D. Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation 1995; 92: 31-38.
64. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987; ii: 986-88.
65. Gris JC, Schved JF, Feugeas O et al. Impact of smoking, physical training and weight reduction on FVII, PAI-1 and hemostatic markers in sedentary men. Thromb Haemost 1990; 64: 516-20.
66. Languino LR, Plescia J, Duperray A et al. Fibrinogen mediates leucocyte adhesion to vascualr endothelium through an ICAM-1 dependent pathway. Cell 1993; 73: 1423-34.
67. Qi J, Kreutzer DZ. Fibrin activation of vascular endothelial cells: induction of IL-8 expression. J Immunol 1995; 155: 867-76.
68. Harley SL, Walton LJ, Powell JT Fibrinogen mediated leucocyte attraction and adhesion to human saphenous vein endothelial cells Immunology 1996; 89: 60.
69. Joensuu T, Salonen R, Winblad I, Korpela H, Salonen JT. Determinants of femoral and carotid artery atherosclerosis. J Intern Med 1994; 236: 79-84.
70. Mailhac A, Badimon JJ, Fallon JT et al. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Circulation 1994; 90: 988-96.
71. Reilly SL, Ferrell RE, Kottke BA, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. Am J Hum Genet 1992; 51(6); 1311-24.
72. Glisic S, Savic I, Alavantic D. Polipoprotein B gene DNA polymorphisms (EcoRI and Mspl) and serum lipid levels in the Serbian healthy population: interaction of rare alleles and smoking and cholersterol levels. Genet Epidemiol 1995; 12(5): 499-508.
73. Freeman DJ, Griffin BA, Holmes AP, Gaffney D, Packard CJ, Shepherd J. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Arterioscler Thromb Vasc Biol 1994; 14: 336-44.
74. Thomas AE, Green FR, Kelleher CH et al. Variation in the promotor region of the β-fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers Thromb Haemost 1991; 65: 487-90.
75. Behague I, Poirier O, Nicaud V et al. β-fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Circulation 1996; 93: 440-49.
76. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 1: 41-45.
77. Margetts BM, Jackson AA. The interactions between people's diet and their smoking habits, the dietary and nutritional survey of British adults. BMJ 1993; 307: 1381-84.
78. Leng GC, Horrobin DF, Fowkes FG et al. Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease. A population-based case-control study. Arterioscler Thromb 1994; 3: 471-78.
79. Brown K, Morrice PC, Duthie GG. Erythrocyte vitamin E and plasma ascorbate concentrations in relation to erythrocyte peroxidation in smokers and nonsmokers: dose response to vitamin E supplementation. Am J Clin Nutr 1997; 2: 496-502.
80. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data BMJ 1989; 6676: 784-88.
81. Craig WY, Palomaki GE, Johnson AM, Haddow JE. Cigarette smoking-associated changes in blood lipid and lipoprotein levels in the 8 to 19 year old age group. Pediatrics 1990; 2: 155-58.
82. Romm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-56.
83. Steinberg D Antioxidant vitamins and coronary heart disease. N Engl J Med 1993, 328: 1487-89.
84. Oliver M. Antioxidant nutrients, atherosclerosis and coronary heart disease. Br Heart J 1995; 73: 299-301.